Investing in research and development is part of a larger strategy to strengthen Canada's economy amid growing global ...

The government launched a two-year pilot of a genomic testing programme, allowing samples to be analysed locally. Health Minister Simeon Brown says it will cut wait times and uncertainty for cancer ...

Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese ...

Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider of diagnostic information services, to ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Cooper Medical School of Rowan University (CMSRU) has launched the PhD in Cancer Cell Biology & Genomics (CCBG), a new ...

Neogen Corp. in Lansing, a leader in food safety solutions, has entered into a definitive agreement to sell its global ...

Facing the loss of his beloved rescue dog, a tech entrepreneur enlisted AI and ChatGPT to co-develop an experimental cancer vaccine.

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...

Wildlife populations that become small and isolated, often due to habitat loss, inevitably experience inbreeding which can ...